Cerenion joins the trans-Atlantic MedTech Bridge program as the only Finnish entrant
Cerenion has been selected to take part in a new two-way program between the Nordics and the USA facilitating the expansion from one medical device market to the other.
The MedTech Bridge program is a non-profit initiative run by the Technical University of Denmark (DTU) and funded by a three-year philanthropic grant totaling $1.3 million from the Danish Industry Foundation. The initiative establishes a bridgehead in the USA via the Medical Alley cluster in Minnesota and fosters the building of a trans-Atlantic community and expedited entryway for Nordic medical device companies looking to enter the US market.
“This new program provides Cerenion with an exciting bridge across the big pond, and a community for solving many common questions regarding, for example, regulatory compliance and business development,” commented Dr. Ilkka Juuso, COO and co-founder of Cerenion.
Cerenion has developed the world’s first practical method for measuring the brain function of intensive care patients. The company is currently actively working on its entry into the US market.